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 Abstract 
 Objectives: We aimed to examine the efficacy of two psycho-oncological interventions in 
anxiety, depression, and self-perceived as well as physiological stress in inpatients with gy-
naecological cancer.  Methods: Forty-five women were included in the trial. Thirty-five were 
categorized as being at high risk of anxiety and depression, and were randomized to either a 
single psycho-oncological therapy session or a single-session relaxation intervention.  Re-
sults: A significant decrease in anxiety [mean (t 0 ) = 12, mean (t 1 ) = 7.47, p = 0.001] and de-
pression [mean (t 0 ) = 9.71, mean (t 1 ) = 6.35, p < 0.001] was observed in the psycho-oncolog-
ical intervention group. In the relaxation group, anxiety also significantly decreased [mean (t 0 ) 
= 11.67, mean (t 1 ) = 8.22, p = 0.003], whereas depression did not. A comparative analysis of 
both interventions showed a trend in favour of psycho-oncological therapy for the treatment 
of depression (F = 3.3, p = 0.078). However, self-reported stress (p = 0.031) and different ob-
jective stress parameters only significantly decreased in the relaxation group.  Conclusions: 
Psycho-oncological interventions should represent an essential part of interdisciplinary care 
for gynaecological cancer patients. Both types of intervention may reduce anxiety. However, 
the single psycho-oncological therapy session might be slightly more effective in treating de-
pression, whereas the single-session relaxation intervention seems to have a stronger effect 
on physiological stress parameters.  © 2014 S. Karger AG, Basel 
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 Introduction 
 A diagnosis of cancer can lead to severe psychological distress. Regardless of the prog-
nosis, patients suffer from the threat of pain and the uncertainty  [1] . In oncological and 
haematological settings, the prevalence of combination diagnoses was 20.7% for any type of 
depression (major, minor, or dysthymia), 31.6% for depression (according to the DSM or ICD) 
or adjustment disorder, and 38.2% for depression (according to the DSM or ICD), adjustment 
disorder, or anxiety  [2] . No differences were found between palliative and non-palliative situ-
ations. The authors of another review suggest that one third of cancer patients in acute care 
hospitals suffer from mental health disorders  [3] . It has been reported that higher stress 
before surgery is associated with increased pain in women undergoing major abdominal 
surgery, which in turn means that they need more morphine  [4] . Furthermore, not only in 
cancer patients do psychiatric comorbidities contribute to prolonged hospital stays and more 
frequent hospital admissions  [5] . Treatment costs have been shown to be higher for depressive 
cancer inpatients  [6] . Moreover, depression significantly influences the severity and frequency 
of side effects  [7] as well as adjustment to and compliance with oncological therapies  [8] .
 Psychiatric comorbidities are most frequently found in women with gynaecological 
cancer  [9] : 43.9% suffered from various mental disorders. However, until today, findings of 
psycho-oncological distress in women with gynaecological cancer are sparse. In line with 
other studies  [10–12] , Singer and Schwarz  [13] report that 78% of women would like to have 
psycho-oncological support already during their inpatient stay.
 An earlier analysis by our research group showed an indication for professional psycho-
oncological support in 41% of the inpatients diagnosed with cancer  [14] . Additionally, in a 
random sample study, we analysed the treatment effect of a psycho-oncological intervention 
versus a non-intervention in 131 inpatients at a hospital specialized in surgical oncology  [15] . 
According to their score on the Hospital Anxiety and Depression Scale (HADS), the patients 
were either classified as ‘at low risk’ (<12) or ‘at high risk of anxiety and depression’ ( ≥ 12). 
A significant decrease in anxiety and depression was found in the high-risk patients under-
going the psycho-oncological intervention. No statistically significant changes could be found 
in the high-risk group without the psycho-oncological intervention as well as in the low-risk 
groups with or without the psycho-oncological intervention.
 The rationale of the present study is based on Lazarus’s stress and coping paradigm  [16, 
17] . In our case, managing stress is coping with the diagnosis of cancer  [18] . Many theories 
consider the activity of the autonomic nervous system as an essential component of emotion 
 [19] , making the assessment of physiological parameters appear to be a useful complement 
to self-reports in assessing stress reactions. In research regarding anxiety, common indi-
cators of an activation of the sympathetic nervous system are breathing rate measured per 
minute, skin conductance measured in microsiemens, heart rate measured per minute, 
amplitude for blood volume pulse measured in microvolts, and muscle activity (electro-
myogram) measured in microvolts. Anxiety leads to an increase in breathing rate, skin 
conductance, heart rate, and electromyogram while the amplitude for blood volume pulse 
decreases  [20] . To our knowledge, until now, physiological parameters have not been used to 
evaluate changes in stress during psychological interventions in cancer patients.
 In contrast to our prior study  [15] which examined the treatment effect of several psycho-
oncological therapy sessions on anxiety and depression, the current study used only one 
session. One-time psychosocial interventions have been shown to be effective in a study by 
Powell et al.  [21] . Guidelines for our single psycho-oncological therapy session were developed 
based on the content-analytical evaluation of our prior study. The originally planned control 
group design was rejected by the local ethics committee for patients at high risk of anxiety 
and depression. Therefore, we chose to analyse whether there are differences in efficacy of a 
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single psycho-oncological therapy session versus a single-session relaxation intervention in 
reducing anxiety, depression, and stress in women with gynaecological cancer. Different 
studies have shown that relaxation training reduces side effects of chemotherapy in cancer 
patients  [22–24] . However, we did not find any study on the treatment effect of single-session 
relaxation interventions. With psycho-oncological therapy being a targeted intervention, we 
assumed the single psycho-oncological therapy session to decrease anxiety and depression 
more strongly than the single-session relaxation intervention. Furthermore, we expected the 
single psycho-oncological therapy session to reduce self-reported stress more efficiently. 
This should also be reflected in physiological stress parameters.
 Patients and Methods 
 Study Design 
 The study has a randomized and prospective design and was approved by the Ethics Board of Charité 
University Hospital (application No. EA01/028/09). It is subject to the Helsinki Declaration as well as the 
terms of data protection and privacy laws. Women with a diagnosis of gynaecological cancer were informed 
about the content and the aims of the study. After declaring their written informed consent, the participants 
were presented the German version of the HADS and the Perceived Stress Questionnaire (PSQ; t 0 ). The HADS 
 [25] is a questionnaire for adults suffering from somatic complaints to self-assess anxiety and depression 
levels. Both subscales contain 7 items. All 14 multiple-choice items have a 4-point Likert response scale. The 
questionnaire yields raw values for each anxiety and depression on a scale from 0 to 21. According to the 
results of other studies  [26, 27] , a sum of 12 of both scales was used as a cutoff score to classify the women 
as at high ( ≥ 12) or at low risk of anxiety and depression (<12). In the high-risk group, the women were 
assigned to either a single psycho-oncological therapy session or a single-session relaxation intervention by 
a randomization list ( fig. 1 ).
 The PSQ  [28] is a self-rating instrument for measuring perceived stressful situations during the last 
month on a 4-point Likert scale. It consists of 4 subscales: worries, tension, joy, and demands. High scores on 
the PSQ are associated with a high level of perceived stress.
 The two types of intervention (see below) took place between the third and sixth postoperative days 
and were conducted by specially trained staff. During both interventions, we measured the physiological 
stress parameters by using a portable NeXus-10 device (Mind Media, Herten, The Netherlands)  [29] . At the 
end of their inpatient stay (t 1 ), the women completed the HADS and PSQ again.
 Single Psycho-Oncological Therapy Session 
 In our prior study  [15] , we identified three essential issues which were important for patients during 
their inpatient stay: (1) information about the inpatient stay, (2) questions regarding communication with 
relatives or friends, and (3) questions regarding their future perspective.
 Thus, the consultations, which lasted at least 30 min, focused on these three issues. Furthermore, the 
women had the opportunity to ask one individual question at the end of the session. No relaxation techniques 
were applied during these consultations.
 Single-Session Relaxation Intervention 
 Progressive muscle relaxation according to Jacobson  [30] is one of the most commonly applied relax-
ation methods and is often used in cancer care. Changes between tension and relaxation have been shown to 
reduce anxiety  [31] . We used the modification by Bernstein and Borkevec  [32] . It is a short intervention and 
includes 16 muscle groups. Following abdominal surgery, abdominal exercises were omitted. We applied a 
standardized procedure which lasted 30 min.
 Participants 
 From April to December 2009, 76 women with gynaecological cancer from the Department of Gynae-
cology at Charité University Hospital were informed about the study. Since 31 women declined to participate, 
45 were enrolled in the study. Reasons for non-participation were, for example, an involvement in other 
clinical trials or reservations about psychological support. The mean age of the attending women was 49.4 
years, ranging from 23 to 79 years. Thirty-five women were considered at high risk ( ≥ 12) and 10 at low risk 
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of anxiety and depression (<12) at the beginning of the study (t 0 ). The women randomized to the single 
psycho-oncological therapy session (n = 17) had higher depression scores at baseline (p = 0.015) than the 
women randomized to the single-session relaxation intervention (n = 18). This difference between the 
groups concerning depression was taken into account by including a priori depression as a covariate. Our 
sample did not have any prior knowledge about relaxation at baseline. The characteristics of the sample are 
shown in  table 1 .
 Statistical Analyses 
 We analysed the data with an intention-to-treat rationale. The scoring of the questionnaires was 
performed according to the test manuals. To compare the groups considering anxiety, depression, and stress 
at baseline, the non-parametric Mann-Whitney test was applied. Results were expressed as arithmetic means 
with standard deviations (SD) or frequencies with percentages. Changes over time in each intervention 
group were ascertained by multivariate ANOVA with repeated measures. For the comparison between both 
interventions, we used ANCOVA models with the baseline characteristics as covariates.
 The physiological stress parameters were measured during the intervention. For analysis, we defined 
3 time points. The first 30 s before the intervention were taken as the baseline. Furthermore, we calculated 
arithmetic means for the first minute and the last minute of the intervention. This procedure was based on 
methodological considerations such as about the time it takes to adapt to the NeXus-10 device and to 
compensate for measurement variations.
 A p value <0.05 was considered statistically significant. Numerical calculations were performed with 
SPSS version 18 (SPSS Inc., Chicago, Ill., USA).
Assessed for eligibility (n = 76)
Declined to participate (n = 31)
Randomized (n = 35)
Participants (n = 45)
Not at high risk of anxiety
and depression
(HADS score <12; n = 10)
Allocated to single psycho-
oncological therapy session (n = 17)
Allocated to single-session
relaxation intervention (n = 18)
Analysed (n = 17)
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 Fig. 1. Study design. 
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 Results 
 Anxiety and Depression 
 We analysed the treatment effect on anxiety and depression (t 1 vs. t 0 ) separately for each 
intervention group. The means and SD for anxiety and depression at the beginning and at the 
end of the hospital stay are shown in  table 2 . A significant decrease in anxiety was found both 
in women undergoing the single psycho-oncological therapy session (F = 41.57, p < 0.001, η 2 
High risk
(n = 35)
Single psycho-
oncological
intervention
(n = 17)
Single-session
relaxation 
intervention
(n = 18)
n % n % n %
Diagnosis
Endometrial cancer 2 5.71 1 5.9 1 5.6
Ovarian carcinoma 9 25.71 4 23.5 5 27.8
Vaginal cancer 1 2.86 0 0 1 5.6
Vulva cancer 2 5.71 1 5.9 1 5.6
Cervical carcinoma 21 60.00 11 64.7 10 55.6
Tumor
T0 1 2.86 0 0 1 5.6
T1 15 42.86 8 47.1 7 38.9
T2 7 20.00 3 17.6 4 22.2
T3 7 20.00 4 23.5 3 16.7
T4 1 2.86 0 0 1 5.6
Unknown1 4 11.43 2 11.8 2 11.1
Involvement of lymph nodes
N0 20 57.14 9 52.9 11 61.1
N1 4 11.43 2 11.8 2 11.1
N2 1 2.86 1 5.9 0 0
Unknown1 10 28.57 5 29.4 5 27.8
Grading
G1 3 8.57 2 11.8 1 5.6
G2 16 45.71 7 41.2 9 50.0
G3 6 17.14 3 17.6 3 16.7
Unknown1 10 28.57 5 29.4 5 27.8
Residual tumor
R0 15 42.86 8 47.1 7 38.9
R1 1 2.86 0 0 1 5.6
R2 1 2.86 1 5.1 0 0
Unknown1 18 51.43 8 47.1 10 55.6
Stage
Primary 23 65.71 10 58.8 13 72.2
Relapse 8 22.86 5 29.4 3 16.7
Secondary 4 11.43 2 11.8 2 11.1
 Metastasis
Yes 9 25.71 4 23.5 5 27.8
No 26 74.29 13 76.5 13 72.2
 1 Since the histological statement was not yet available at the time 
of discharge, the number of ‘unknowns’ is high.
 Table 1.  Characteristics of the 
sample
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= 0.72) and in those undergoing the single-session relaxation intervention (F = 12.5, p = 0.003, 
η 2 = 0.42). In women who had the single psycho-oncological therapy session, a significant 
decrease was also found for depression (F = 27.82, p < 0.001, η 2 = 0.63). However, the levels 
of depression did not change in women who had the single-session relaxation intervention (F 
= 1.54, p = 0.231, η 2 = 0.08).
 A comparative analysis of both interventions showed no differences in treatment effects 
on anxiety (F = 2.5, p = 0.124;  fig. 2 ). However, considering depression, we found a trend in 
favour of the single psycho-oncological therapy session (F = 3.3, p = 0.078;  fig. 3 ).
 Self-Reported Stress 
 Analogously, we analysed the treatment effect of each of the two interventions on self-
reported stress (t 1 vs. t 0 ). For the patients who had the single psycho-oncological therapy 
session, the scores for worries (F = 2.7, p = 0.12, η 2 = 0.14), tension (F = 0.007, p = 0.93, η 2 < 
0.001), joy (F = 2.4, p = 0.14, η 2 = 0.13), demands (F < 0.001, p = 1, η 2 < 0.001), and total self-
reported stress (F = 0.95, p = 0.34, η 2 = 0.06) did not change significantly; the same was true 
for the patients who had the single-session relaxation intervention (worries: F = 1.15, p = 
0.29, η 2 = 0.07; tension: F = 1.35, p = 0.26, η 2 = 0.08; joy: F = 0.7, p = 0.41, η 2 = 0.04; demands: 
F = 3.35, p = 0.08, η 2 = 0.17; total self-reported stress: F = 2.56, p = 0.11, η 2 = 0.15).
 The comparison of the two types of intervention did not show any significant difference 
in self-reported stress scores between the two treatments regarding tension (F = 0.44, p = 
0.25, η 2 = 0.01), joy (F = 2.76, p = 0.53, η 2 = 0.80), and demands (F = 2.85, p = 0.05, η 2 = 0.82). 
t0 (admission
to the hospital)
t1 (discharge
from the hospital)
p
value
Single psycho-oncological intervention
Anxiety 12 ± 2.85 7.47 ± 2.78 <0.001
Depression 9.71 ± 3.42 6.35 ± 3.39 <0.001
Single-session relaxation intervention
Anxiety 11.67 ± 2.78 8.22 ± 3.02 <0.003
Depression 6.78 ± 3.3 5.72 ± 4.05 0.231
Values denote means ± SD unless specified otherwise. Significant 
results are set in italics.
 Table 2. Changes in anxiety and 
depression scores in each 
intervention group
0
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Anxiety t0 Anxiety t1
p = 0.124
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Single psycho-oncological intervention
Single-session relaxation intervention
(95% CI)
 Fig. 2. Effect of treatment on
anxiety. 
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 Fig. 3. Effect of treatment on
depression. 
Table 3. Changes in self-reported stress and objective stress parameters between both intervention groups
a Physiological parameters
Single psycho-
oncological therapy
Single-session
relaxation intervention
p value
Worries t0 29.80 ± 20.01 37.25 ± 20.42 0.044
Worries t1 32.94 ± 15.36 33.73 ± 17.86
Tension t0 49.80 ± 20.83 48.24 ± 17.08 0.255
Tension t1 49.41 ± 16.34 43.92 ± 17.96
Joy t0 53.33 ± 21.73 56.47 ± 17.33 0.053
Joy t1 47.45 ± 15.07 60.00 ± 18.85
Demands t0 36.86 ± 25.83 54.12 ± 28.46 0.053
Demands t1 36.86 ± 22.74 47.06 ± 25.10
Total score t0 40.78 ± 16.38 45.78 ± 17.29 0.031
Total score t1 42.94 ± 12.91 41.18 ± 16.82
b Physiological parameters
Breathing rate, breaths/min
Baseline 25.62 ± 2.83 25.67 ± 4.43 0.014
First minute 27.07 ± 4.42 21.29 ± 4.19
Last minute 27.30 ± 4.43 20.22 ± 7.09
Skin conductance, μS
Baseline 2.553 ± 1.05 1.261 ± 0.34 0.362
First minute 2.263 ± 0.99 1.034 ± 0.36
Last minute 2.684 ± 1.42 0.932 ± 0.54
Heart rate, beats/min
Baseline 82.36 ± 14.17 89.59 ± 17.55 0.578
First minute 81.68 ± 16.06 90.29 ± 19.95
Last minute 81.58 ± 16.68 90.57 ± 18.47
Amplitude for blood volume pulse, μV
Baseline 50.79 ± 23.53 47.38 ± 26.58 0.077
First minute 53.74 ± 24.92 43.97 ± 21.26
Last minute 43.45 ± 20.95 30.62 ± 11.68
Electromyogram, μV
Baseline 20.76 ± 10.59 19.09 ± 9.91 0.169
First minute 14.95 ± 2.67 17.52 ± 9.80
Last minute 18.72 ± 7.33 13.46 ± 8.27
Values denote means ± SD unless specified otherwise. Significant results are set in italics.
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In contrast, changes in worries (F = 3.07, p = 0.044, η 2 = 0.088) and total self-reported stress 
(F = 3.71, p = 0.03, η 2 = 0.11) significantly differed between the two groups. Worries and total 
self-reported stress tended to increase in the psycho-oncological therapy group, whereas a 
decrease was observed in the single-session relaxation group ( table 3 a).
 Physiological Parameters 
 In addition, we analysed objective stress parameters ( table 3 b). During the single psycho-
oncological therapy session, the breathing rate (F = 0.36, p = 0.71, η 2 = 0.09), the skin conduc-
tance (F = 4.56, p = 0.06, η 2 = 0.57), the heart rate (F = 0.07, p = 0.93, η 2 = 0.02), the amplitude 
for blood volume pulse (F = 3.49, p = 0.09, η 2 = 0.49), and the electromyogram (F = 1.56, p = 
0.29, η 2 = 0.38) did not change significantly. In contrast, during the single-session relaxation 
intervention, the breathing rate (F = 5.28, p = 0.03, η 2 = 0.51), the skin conductance (F = 10.44, 
p = 0.004, η 2 = 0.67), and the electromyogram (F = 4.84, p = 0.03, η 2 = 0.49) significantly 
decreased. No significant changes were found for blood volume pulse (F = 2.08, p = 0.17, η 2 = 
0.29) and heart rate (F = 0.26, p = 0.77, η 2 = 0.05).
 The intervention groups differed in skin conductance already at baseline. The value for this 
parameter was significantly higher in women expecting the single psycho-oncological therapy 
session than in women anticipating the single-session relaxation intervention (F = 17.39, p = 
0.001, η 2 = 0.48). This also held for the first (F = 19.0, p < 0.001, η 2 = 0.48) and the last minute 
of the intervention (F = 20.23, p < 0.001, η 2 = 0.52). In addition, the breathing rate was signifi-
cantly higher in the psycho-oncological therapy group than in the single-session relaxation 
group in the first and the last minute of the intervention (first: F = 6.47, p = 0.02, η 2 = 0.25; last: 
F = 5.83, p = 0.02, η 2 = 0.23). Finally, a significantly higher blood volume pulse in the last inter-
vention minute was found in the psycho-oncological therapy group compared with the single-
session relaxation group (F = 5.44, p = 0.03, η 2 = 0.22). The comparison of both interventions 
over time shows a significantly larger decrease in breathing rate in the single-session relax-
ation intervention than in the psycho-oncological therapy session (F = 7.46, p = 0.01, η 2 = 0.29). 
All other physiological stress parameters did not reach statistical significance ( table 3 b).
 Discussion 
 The aim of our study was to examine the treatment effect of two different psycho-onco-
logical interventions on anxiety, depression, and self-perceived as well as physiological stress 
in women with gynaecological cancer in an inpatient setting. A high percentage of our sample 
of women with gynaecological cancer was identified as being at high risk of anxiety and 
depression (78%). This finding clearly points to psycho-oncological distress in the majority 
of female inpatients diagnosed with cancer.
 Our prior results provide evidence for the efficacy of psycho-oncological interventions in 
reducing anxiety and depression compared with a non-intervention  [15] . In the current study, 
our first hypothesis was that anxiety and depression can be reduced more efficiently by a 
single psycho-oncological therapy session than by a single-session relaxation intervention. 
Our findings show a significant decrease in anxiety for both intervention groups, whereas 
depression significantly decreased in the single psycho-oncological therapy group only. 
However, between-group analyses showed merely a small tendency in favour of the psycho-
oncological therapy session versus the relaxation intervention in reducing depression. In line 
with our prior study  [15] , these results indicate that psycho-oncological interventions might 
reduce psychological distress during an inpatient stay. However, we could not find clear 
evidence supporting the stronger treatment effect of the targeted single psycho-oncological 
therapy session as compared with the single-session relaxation intervention.
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 Further, we assumed the single psycho-oncological therapy session to reduce self-
reported stress more efficiently than the single-session relaxation intervention. In our mixed 
gynaecological cancer sample, self-reported stress was high compared with a sample of 
women with breast cancer  [33] . However, we did not find a positive treatment effect on self-
reported stress with either type of intervention. Moreover, comparing the two groups, worries 
and total self-reported stress tended to increase in the psycho-oncological therapy group. In 
contrast, at the same time, depression tended to decrease only after the psycho-oncological 
therapy session. One explanation might be that the HADS depression scale and the PSQ scales 
differ in content. Whereas the depression scale (HADS) focuses on a loss of interest and 
pleasure, the PSQ assesses the subjective perception, evaluation, and further processing of 
stressors on different scales, such as ‘worries’. In the psycho-oncological therapy session, 
women are confronted with their current situation. This confrontation may have triggered 
more worries in patients, but nonetheless it may have been more effective in treating the 
principal symptoms of depression.
 Finally, we expected changes in self-reported stress to be reflected in the objective stress 
parameters. In accordance with the results concerning self-reported stress, no decreases 
were found in the psycho-oncological therapy group. However, the relaxation intervention 
group showed a significant decrease in breathing rate, skin conductance, and electromyogram. 
Interestingly, the single-session relaxation group already had a lower skin conductance at 
baseline as well as a lower breathing rate and blood volume pulse throughout the session 
than the single psycho-oncological therapy group. Furthermore, the relaxation group showed 
a larger decrease in breathing rate.
 Thus, the physiological data indicate that there was less stress in the single-session relax-
ation group. We assume the anticipation of relaxation and its effects on patients caused these 
results. From a clinical point of view, this finding suggests that anticipated relaxation might 
be a useful intervention mechanism, too. Further research is needed to analyse this aspect in 
more detail. Nevertheless, objective stress parameters appear to provide additional infor-
mation that is not taken into account by self-assessment tools. Thus, the consideration of 
objective stress parameters might be a promising way of achieving a better understanding of 
the differential treatment effects of different interventions.
 A similar study by Powell et al.  [21] in women attending a gynaecological cancer clinic 
focused on the effect of a 1-hour psychosocial intervention on specific psychosocial outcomes 
including anxiety and depression. The authors reported decreased anxiety and depression 
scores in the intervention group and decreased anxiety, but increased depression scores in 
the control group without the intervention. In this study, all patients were included inde-
pendent of their anxiety and depression scores. However, the results of our first study  [15] 
highlight the necessity of seriously considering the level of psycho-oncological distress in 
patients: in contrast to the high-risk group, we could not find a treatment effect of the inter-
vention compared with the non-intervention (observation) on anxiety and depression in the 
low-risk group. Furthermore, considering the limited psycho-oncological resources, it is 
important to focus on patients with high scores of anxiety and depression.
 A limitation of our study is the reduced external validity due to its rather small sample 
size. Thus, final conclusions cannot be drawn. In our study, the rate of refusal was high (40%), 
but it corresponds to other studies  [34] . At university hospitals, a variety of clinical studies 
are offered to patients. Aschenbrenner et al.  [35] noted that patients with a great psycho-
logical burden often drop out of psychological studies.
 For clinical trials, a randomized study design is considered the gold standard. However, 
it is not clear whether a preference for a specific type of intervention might influence the 
motivation of participants  [36] . To analyse this question, a study design should be used which 
allows patients to select the type of intervention. On the other hand, considering our previous 
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result that the levels of anxiety and depression do not change without psycho-oncological 
intervention  [15] and the current results that different types of interventions positively 
influence different aspects of psychological distress, future studies should also consider 
investigating the effects of interventions combining both psycho-oncological and relaxation 
sessions.
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